The new fragrance frontier: what you need to know about biotech in the perfumery world - From enabling more sustainable ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

XBI is a biotech-focused ETF offering equal-weight exposure to U.S. biotechnology companies. The SPDR S&P Biotech ETF tracks the performance of the S&P Biotechnology Select Industry Index. XBI ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Alex Ossola: U.S. hiring slowed in January, but remained solid in the last jobs ...

A drug launch is one of the most defining events in the pharma and biotech lifecycle. It marks the moment a therapy moves from years of research and clinical testing into real world availability for ...